Physician profile
Stanley Swierzewski
NPI 1548230717
$2,458.32
in general payments reported to CMS, 2019-2025
17 companies · $27.50 in 2025
The $27.50 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $69.87 · 2021: $328 · 2022: $148 · 2023: $1,150 · 2024: $56.01 · 2025: $27.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $991 · Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $990.87 |
| Food and Beverage | $242.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,057.87 | 2023 | Aquabeam Robotic System |
| Abbvie INC. | $242.01 | 2019-2020 | |
| Janssen Biotech, INC. | $214.52 | 2019 | |
| Astellas Pharma US INC | $201.69 | 2019-2023 | Myrbetriq |
| Medtronic, INC. | $181.15 | 2021 | |
| Coloplast Corp | $137.75 | 2021-2022 | |
| Boston Scientific Corporation | $70.74 | 2021-2022 | |
| Axonics, INC. | $59.29 | 2022-2023 | Axonics |
| Teleflex LLC | $56.01 | 2024 | Urolift |
| Pfizer INC. | $53.00 | 2019-2020 | |
| 180 Medical, INC. | $48.43 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $34.96 | 2019-2021 | |
| Olympus America INC. | $27.50 | 2025 | Itind System |
| Progenics Pharmaceuticals, INC. | $27.23 | 2023 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $16.84 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.36 | 2019 | |
| Urovant Sciences INC | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Swierzewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.